share_log

Bee Vectoring Technologies Closes Non-Brokered Private Placement and Debt Settlement

Bee Vectoring Technologies Closes Non-Brokered Private Placement and Debt Settlement

蜜蜂矢量化技術關閉非代理私人配售和債務結算
newsfile ·  2023/03/07 05:45

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - March 6, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce that it has closed a non-brokered private placement of 1,491,667 units (the "Units") issued at a price of $0.12 per Unit for gross aggregate proceeds of $179,000 (the "Private Placement"). Each Unit is comprised of one common share (each a "Share") and one common share purchase warrant (each a "Warrant"). Each Warrant is exercisable to acquire one additional Share of the Company for a period of 36 months from closing at a price of $0.20.

安大略省密西索加和加利福尼亞州薩克拉門託-(新聞文件公司-2023年3月6日)-蜜蜂矢量化技術國際公司。(CSE:BEE)(OTCQB:BEVVF)(CVE:BEE)(“公司”或“BVT”)欣然宣佈,已完成1,491,667個單位(“單位”)的非經紀私募,以每單位0.12元的價格發行,總收益為179,000元(“該等單位”)私募“)。每個單位由一個公用股組成(每個”分享“)及一份普通股認購權證(每份均為”搜查令每份認股權證可行使購入本公司額外一股股份的權力,為期36個月,由收市價0.20美元起計。

The Company paid $840.00 in cash and issued 7,000 Warrants on the same terms noted above to qualified parties in connection with the Private Placement. The Company intends to use the gross proceeds from the Private Placement to fund its ongoing growth strategy in the agricultural space, for continued research and development and general working capital purposes.

本公司按上述相同條款向合資格人士支付840.00美元現金及發行7,000份認股權證,以供私人配售。該公司打算利用私募的總收益為其在農業領域的持續增長戰略提供資金,用於繼續研究和開發以及一般營運資金用途。

The Company also announces that it has entered into a debt settlement agreement (the "Settlement Agreement") to settle an outstanding cash payment owed to an arm's length creditor in the amount of $157,180 for consulting fees (the "Debt Settlement"). Pursuant to the Settlement Agreement, the Company has issued an aggregate of 1,310,000 Shares to the creditor at a deemed price of $0.12 per Share.

本公司亦宣佈,已訂立債務清償協議(“和解協議“)清償欠獨立債權人的未清現金顧問費157,180元(”清償債務根據和解協議,本公司已向債權人發行合共1,310,000股股份,每股作價0.12美元。

All securities issued pursuant to the Private Placement and Debt Settlement are subject to a statutory hold period that will expire on July 7, 2023, in accordance with applicable securities laws.

根據適用的證券法,根據私募和債務結算髮行的所有證券均受2023年7月7日到期的法定持有期的約束。

None of the securities issued in connection with the Private Placement have been registered under the United States Securities Act of 1933, as amended (the "1933 Act"), and none of them have been offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.

與私募相關發行的證券均未根據經修訂的《1933年美國證券法》(下稱《1933年法案》)進行註冊,也未在沒有註冊或未獲得1933年法案註冊要求的適用豁免的情況下在美國發售或出售。本新聞稿不應構成出售要約或邀請購買要約,也不應在任何這樣的要約、招攬或出售將是非法的任何州出售證券。

About Bee Vectoring Technologies International Inc.

關於蜜蜂矢量化技術國際公司.

BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT's award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides - and improving the health of the soil, the microbiome and the environment. Currently, BVT has over 65 granted patents, over 35 patents pending in all major agricultural countries worldwide and has US EPA registration of its Vectorite with CR-7 (EPA Registration No. 90641-2) for sale as a registered biological fungicide for use on the labeled crops.

BVT是一家農業技術公司,在2400億美元的作物保護和化肥市場上具有巨大的全球市場機會,是市場顛覆者。BVT開創了一種天然精準農業系統,通過使用商業培育的蜜蜂為作物提供生物農藥替代品,取代了化學農藥和浪費的植物保護產品噴霧應用。BVT的獲獎技術精密矢量化對蜜蜂完全無害,允許微量的天然衍生殺蟲劑(稱為生物製品)直接輸送到花朵中,提供比傳統化學殺蟲劑更好的作物保護和產量結果-並改善土壤、微生物羣和環境的健康。目前,BVT擁有超過65項已授予專利,超過35項專利在全球所有主要農業國家懸而未決,並已將其Vectorite在美國環保局CR-7註冊(環保局註冊號90641-2),作為註冊生物殺菌劑出售,用於標籤作物。

Additional information can be viewed at the Company's website . To receive regular news updates from the Company, subscribe at .

欲瞭解更多信息,請訪問公司網站。. 要定期接收本公司的最新新聞,請訂閲.

Company Contact:
Ashish Malik, President & CEO
info@beevt.com

公司聯繫人:
阿什什·馬利克,總裁首席執行官
郵箱:info@beevt.com

Investor Contacts:
Babak Pedram (Canada & International)
Virtus Advisory Group
Tel: 416-995-8651
bpedram@virtusadvisory.com

投資者聯繫方式:
Babak Pedram(加拿大和國際)
Virtus顧問團
電話:416-995-8651
郵箱:bpedram@virtusvisory.com

William Maze (United States)
RB Milestone Group LLC (RBMG)
bee@rbmilestone.com

威廉·梅茲(美國)
RB里程碑集團有限責任公司(RBMG)
郵箱:bee@rbmilestone.com

The CSE has neither approved nor disapproved the contents of this press release. The CSE does not accept responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company, "annual revenue potential", are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include changes in law, competition, litigation, the ability to implement business strategies and pursue business opportunities, state of the capital markets, the availability of funds and resources to pursue operations, new technologies, the ability to protect intellectual property rights, the ability to obtain patent protection for products, third-party intellectual property infringement claims, regulatory changes affecting products, failing research and development activities, the ability to reach and sustain profitability, dependence on business and technical experts, the ability to effectively manage business operations and growth, issuance of debt, dilution of existing securities, volatility of publicly traded securities, potential conflicts of interest, unlikelihood of dividend payments, the potential costs stemming from defending third-party intellectual property infringement claims, the ability to secure relationships with manufacturers and purchasers, as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company's Filing Statement dated August 14,2020, filed with the CSE and securities regulatory authorities in certain provinces of Canada and available at . Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. All figures are in Canadian dollars.

CSE既沒有批准也沒有反對本新聞稿的內容。CSE不對本新聞稿的充分性或準確性承擔責任。本新聞稿中包含的某些陳述構成“前瞻性信息”,這一術語在適用的加拿大證券法中有定義。“可能”、“應該”、“潛在”、“將”、“尋求”、“打算”、“計劃”、“預期”、“相信”、“估計”、“預期”以及與公司有關的類似表述“年度收入潛力”,旨在識別前瞻性信息。除歷史事實以外的所有陳述都可能是前瞻性信息。此類陳述反映了公司目前對未來事件的看法和意圖,以及公司目前掌握的信息,可能會受到某些風險、不確定因素和假設的影響。在提供前瞻性信息時採用了重大因素或假設。如果這些風險或不確定性中的一個或多個成為現實,許多因素可能會導致這些前瞻性信息可能表達或暗示的實際結果、業績或成就與本文描述的結果、業績或成就不同。這些因素包括法律的變化、競爭、訴訟、執行商業戰略和尋求商業機會的能力、資本市場的狀況、開展業務的資金和資源的可獲得性、新技術、保護知識產權的能力、獲得產品專利保護的能力、第三方知識產權侵權索賠、影響產品的監管變化、研發活動失敗、達到和維持盈利的能力、對商業和技術專家的依賴、有效管理業務運營和增長的能力、債務發行。, 這些風險包括現有證券的稀釋、上市證券的波動性、潛在的利益衝突、派息的可能性、為第三方知識產權侵權索賠辯護而產生的潛在成本、與製造商和購買者建立關係的能力、總體經濟、市場和商業狀況,以及公司於2020年8月14日提交給加拿大某些省份的證券監管機構提交給CSE和證券監管機構的文件中討論或提到的風險因素。如果任何因素以意想不到的方式影響公司,或者前瞻性信息背後的假設被證明是不正確的,實際結果或事件可能與預測的結果或事件大不相同。任何此類前瞻性信息都明確地受到本警示聲明的限制。此外,公司不對此類前瞻性信息的準確性或完整性承擔責任。本新聞稿中包含的前瞻性信息是截至本新聞稿發佈之日的信息,除適用法律要求外,公司沒有義務公開更新或修改任何前瞻性信息。所有數字都是以加元計算的。

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
FOR DISSEMINATION IN THE UNITED STATES

本新聞稿不向美國新聞通訊社分發
在美國傳播

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論